Knowledge Graph

Graph explorer

Search resolved entities, walk their edges, and read the sentence behind every one.

Entities25 of 207,987

Entity

BDC-4182

product1 mentionslast seen Oct 23, 2026

Claudin 18.2-targeting immune-stimulating antibody conjugate in Phase 1 development for metastatic gastric or gastroesophageal cancer.

Relationships 2

Relationship

Bolt Biotherapeutics, Inc.developsBDC-4182

88% confidence1 supporting mentions

Either name opens that entity’s relationships.

Sources 1

filingSEC EDGAROct 23, 2026Bolt Biotherapeutics, Inc. 8-K: Item 1.01: Entry into a Material Definitive Agreement; Item 1.02: Termination of a Material Definitive Agreement; Item 2.01: Completion of Acquisition or Disposition of Assets; Item 3.02: Unregistered Sales of Equity Securities; Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers; Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year; Item 7.01: Regulation FD Disclosure; Item 8.01: Other Events; Item 9.01: Financial Statements and Exhibits
BDC-4182, a claudin 18.2-targeting immune-stimulating antibody conjugate, in a Phase 1 dose-escalation study